Previous Page  8 / 30 Next Page
Information
Show Menu
Previous Page 8 / 30 Next Page
Page Background

Real world data_ Baseline mCRC

47% RAS mutant (93/198)

Median concentration= 0,26 ng/ml [0,08-7,32] 100-fold

Median RAS MAF= 6,3% [0,01%-42%] 4200-fold

RAS

mutation

status

Anti-

EGFR

therapy

Tissue

blood

WT

Chemotherap

y

(e.g. FOLFIRI)

MUT

Monitoring of

RAS mutation

status

T0 T1 T2

MUT

No tissue

Anti-EGFR Re-challenge?